Niagen Bioscience, Inc. (NAGE) Cash From Operations

Annual CFO:

$12.06M+$5.01M(+71.22%)
December 31, 2024

Summary

  • As of today, NAGE annual cash from operations is $12.06 million, with the most recent change of +$5.01 million (+71.22%) on December 31, 2024.
  • During the last 3 years, NAGE annual cash from operations has risen by +$36.33 million (+149.67%).
  • NAGE annual cash from operations is now at all-time high.

Performance

NAGE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Quarterly CFO:

$3.69M+$2.45M(+196.78%)
September 30, 2025

Summary

  • As of today, NAGE quarterly cash from operations is $3.69 million, with the most recent change of +$2.45 million (+196.78%) on September 30, 2025.
  • Over the past year, NAGE quarterly cash from operations has increased by +$197.00 thousand (+5.64%).
  • NAGE quarterly cash from operations is now -56.78% below its all-time high of $8.54 million, reached on December 31, 2024.

Performance

NAGE Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

TTM CFO:

$21.36M+$197.00K(+0.93%)
September 30, 2025

Summary

  • As of today, NAGE TTM cash from operations is $21.36 million, with the most recent change of +$197.00 thousand (+0.93%) on September 30, 2025.
  • Over the past year, NAGE TTM cash from operations has increased by +$17.27 million (+422.25%).
  • NAGE TTM cash from operations is now at all-time high.

Performance

NAGE TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NAGE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+71.2%+5.6%+422.3%
3Y3 Years+149.7%+198.3%+207.9%
5Y5 Years+157.1%+196.0%+278.9%

NAGE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+149.7%-56.8%+198.3%at high+207.9%
5Y5-Yearat high+149.7%-56.8%+146.8%at high+182.1%
All-TimeAll-Timeat high+149.7%-56.8%+140.9%at high+182.1%

NAGE Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$3.69M(+196.8%)
$21.36M(+0.9%)
Jun 2025
-
$1.24M(-84.2%)
$21.16M(+7.7%)
Mar 2025
-
$7.88M(-7.8%)
$19.65M(+63.0%)
Dec 2024
$12.06M(+71.2%)
$8.54M(+144.4%)
$12.06M(+194.9%)
Sep 2024
-
$3.50M(+1423.9%)
$4.09M(+313.0%)
Jun 2024
-
-$264.00K(-193.0%)
$990.00K(-78.2%)
Mar 2024
-
$284.00K(-50.5%)
$4.53M(-35.6%)
Dec 2023
$7.04M(+146.4%)
-
-
Dec 2023
-
$574.00K(+44.9%)
$7.04M(+15.9%)
Sep 2023
-
$396.00K(-87.9%)
$6.08M(+215.4%)
Jun 2023
-
$3.28M(+17.5%)
$1.93M(+137.2%)
Mar 2023
-
$2.79M(+815.9%)
-$5.18M(+65.8%)
Dec 2022
-$15.18M(+37.5%)
-$390.00K(+89.6%)
-$15.18M(+23.3%)
Sep 2022
-
-$3.75M(+2.0%)
-$19.79M(+9.9%)
Jun 2022
-
-$3.83M(+46.8%)
-$21.96M(+15.6%)
Mar 2022
-
-$7.20M(-43.8%)
-$26.02M(-7.2%)
Dec 2021
-$24.27M(-127.9%)
-$5.01M(+15.4%)
-$24.27M(-26.0%)
Sep 2021
-
-$5.92M(+25.1%)
-$19.26M(-12.1%)
Jun 2021
-
-$7.90M(-44.9%)
-$17.19M(-58.2%)
Mar 2021
-
-$5.45M(>-9900.0%)
-$10.86M(-2.0%)
Dec 2020
-$10.65M(+49.6%)
$3000.00(+100.1%)
-$10.65M(+10.8%)
Sep 2020
-
-$3.85M(-144.7%)
-$11.94M(+24.7%)
Jun 2020
-
-$1.57M(+70.0%)
-$15.86M(+32.0%)
Mar 2020
-
-$5.24M(-306.5%)
-$23.30M(-10.4%)
Dec 2019
-$21.12M(-0.9%)
-$1.29M(+83.4%)
-$21.12M(+15.5%)
Sep 2019
-
-$7.76M(+14.0%)
-$24.98M(-11.2%)
Jun 2019
-
-$9.02M(-196.0%)
-$22.46M(-12.4%)
Mar 2019
-
-$3.05M(+40.9%)
-$19.98M(+4.5%)
Dec 2018
-$20.93M(-111.8%)
-$5.16M(+1.5%)
-$20.93M(-7.0%)
Sep 2018
-
-$5.24M(+20.0%)
-$19.56M(-31.7%)
Jun 2018
-
-$6.54M(-63.8%)
-$14.85M(-7.5%)
Mar 2018
-
-$4.00M(-5.3%)
-$13.82M(-39.9%)
Dec 2017
-$9.88M(-217.3%)
-$3.79M(-623.1%)
-$9.88M(-62.7%)
Sep 2017
-
-$524.50K(+90.5%)
-$6.07M(-6.8%)
Jun 2017
-
-$5.51M(>-9900.0%)
-$5.69M(-2020.0%)
Mar 2017
-
-$51.00K(-454.2%)
-$268.30K(+91.4%)
Dec 2016
-$3.11M
$14.40K(+110.3%)
-$3.11M(+21.8%)
Sep 2016
-
-$140.40K(-53.8%)
-$3.98M(+13.5%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$91.30K(+96.8%)
-$4.60M(-4.2%)
Mar 2016
-
-$2.90M(-239.3%)
-$4.42M(-109.2%)
Dec 2015
-$2.11M(+18.2%)
-$853.60K(-12.3%)
-$2.11M(-40.4%)
Sep 2015
-
-$760.40K(-909.8%)
-$1.50M(-33.1%)
Jun 2015
-
$93.90K(+115.9%)
-$1.13M(+36.1%)
Mar 2015
-
-$591.10K(-140.6%)
-$1.77M(+31.5%)
Dec 2014
-$2.58M(+33.9%)
-$245.70K(+36.4%)
-$2.58M(+36.6%)
Sep 2014
-
-$386.50K(+28.9%)
-$4.07M(-7.9%)
Jun 2014
-
-$543.40K(+61.3%)
-$3.77M(+18.2%)
Mar 2014
-
-$1.40M(+18.9%)
-$4.61M(-17.9%)
Dec 2013
-$3.91M(+61.4%)
-$1.73M(-1889.4%)
-$3.91M(-33.6%)
Sep 2013
-
-$87.10K(+93.7%)
-$2.92M(+24.2%)
Jun 2013
-
-$1.38M(-95.6%)
-$3.85M(+37.5%)
Mar 2013
-
-$705.80K(+5.9%)
-$6.17M(+39.0%)
Dec 2012
-$10.12M(-146.9%)
-$749.80K(+26.4%)
-$10.12M(+7.8%)
Sep 2012
-
-$1.02M(+72.4%)
-$10.97M(+3.7%)
Jun 2012
-
-$3.70M(+20.6%)
-$11.39M(-26.5%)
Mar 2012
-
-$4.66M(-190.8%)
-$9.00M(-119.6%)
Dec 2011
-$4.10M(-54.0%)
-$1.60M(-11.4%)
-$4.10M(-22.5%)
Sep 2011
-
-$1.44M(-10.0%)
-$3.34M(-48.6%)
Jun 2011
-
-$1.31M(-628.7%)
-$2.25M(+12.7%)
Mar 2011
-
$247.30K(+129.2%)
-$2.58M(+3.1%)
Dec 2010
-$2.66M(-571.8%)
-$846.80K(-146.2%)
-$2.66M(-58.3%)
Sep 2010
-
-$343.90K(+79.0%)
-$1.68M(-19.3%)
Jun 2010
-
-$1.63M(-1096.3%)
-$1.41M(-7440.1%)
Mar 2010
-
$164.10K(+22.8%)
$19.20K(+104.8%)
Dec 2009
-$396.20K(+79.4%)
$133.60K(+285.3%)
-$396.20K(+47.7%)
Sep 2009
-
-$72.10K(+65.1%)
-$758.10K(+50.4%)
Jun 2009
-
-$206.40K(+17.9%)
-$1.53M(+29.7%)
Mar 2009
-
-$251.30K(-10.1%)
-$2.17M(-13.1%)
Dec 2008
-$1.92M(-4890.6%)
-$228.30K(+72.9%)
-$1.92M(-13.2%)
Sep 2008
-
-$842.40K(+1.0%)
-$1.70M(-97.6%)
Jun 2008
-
-$850.70K(>-9900.0%)
-$858.60K(-7850.0%)
Feb 2008
-
$0.00(+100.0%)
-$10.80K(+71.9%)
Nov 2007
-$38.50K(-4177.8%)
-$3600.00(+16.3%)
-$38.40K(-10.3%)
Aug 2007
-
-$4300.00(-48.3%)
-$34.80K(-14.1%)
May 2007
-
-$2900.00(+89.5%)
-$30.50K(-10.5%)
Feb 2007
-
-$27.60K
-$27.60K
Nov 2006
-$900.00
-
-

FAQ

  • What is Niagen Bioscience, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual cash from operations year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly cash from operations year-on-year change?
  • What is Niagen Bioscience, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. TTM cash from operations year-on-year change?

What is Niagen Bioscience, Inc. annual cash from operations?

The current annual cash from operations of NAGE is $12.06M

What is the all-time high annual cash from operations for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual cash from operations is $12.06M

What is Niagen Bioscience, Inc. annual cash from operations year-on-year change?

Over the past year, NAGE annual cash from operations has changed by +$5.01M (+71.22%)

What is Niagen Bioscience, Inc. quarterly cash from operations?

The current quarterly cash from operations of NAGE is $3.69M

What is the all-time high quarterly cash from operations for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly cash from operations is $8.54M

What is Niagen Bioscience, Inc. quarterly cash from operations year-on-year change?

Over the past year, NAGE quarterly cash from operations has changed by +$197.00K (+5.64%)

What is Niagen Bioscience, Inc. TTM cash from operations?

The current TTM cash from operations of NAGE is $21.36M

What is the all-time high TTM cash from operations for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high TTM cash from operations is $21.36M

What is Niagen Bioscience, Inc. TTM cash from operations year-on-year change?

Over the past year, NAGE TTM cash from operations has changed by +$17.27M (+422.25%)
On this page